SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

12 Jun 2009 16:03

RNS Number : 8456T
Rentokil Initial PLC
12 June 2009
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).

Β 

(1)

AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should completeΒ boxes 1 to 16, 23 and 24.

(2)

AnΒ issuerΒ making a notification in respect of a derivative relatingΒ toΒ theΒ sharesΒ of theΒ issuerΒ should completeΒ boxes 1 to 4, 6, 8,Β 13, 14, 16, 23 and 24.Β 

(3)

AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should completeΒ boxes 1 to 3Β and 17 to 24.Β 

(4)

AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β 

Β 

Please complete all relevant boxes in block capital letters.

1.Β Name of theΒ issuer

Rentokil Initial plc

2.Β State whether the notification relates to (i) a transaction notified in accordance withΒ DRΒ 3.1.4R(1)

(a); or

(ii)Β DRΒ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; orΒ 

(iii) both (i) and (ii)

Pursuant toΒ (i) and (ii) above

3.Β Name ofΒ person discharging managerial responsibilities/director

a) Alan Brownb) Andy Ransomc) Michael Murray

d) Petar Cvetkovic

e) Andy Hobartf) Martin Sawkins

g) Bryan Kinsellah) Peter Lloyd

i) Peter Slator

4.Β State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

Not applicable

5.Β Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

Pursuant to 3. above

6.Β Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

Ordinary shares of 1 pence each

7.Β Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

Not applicable

8Β State the nature of the transaction

Awards under theΒ 2006Β Performance Share PlanΒ - 2009Β award

9.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

Not applicable

10.Β Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

Not applicable

11.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

Not applicable

12.Β Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β 

Not applicable

13.Β Price perΒ shareΒ or value of transaction

Not applicable

14.Β Date and place of transaction

Not applicable

15.Β Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)

Not applicable

16.Β Date issuer informed of transaction

Not applicable

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

17.Β Date of grant

12 JuneΒ 2009Β - Performance Share Plan award

18.Β Period during which or date on which it can be exercised

12 JuneΒ 2012Β toΒ 11 JuneΒ 2019Β (subject to performance conditions)

19.Β Total amount paid (if any) for grant of the option

Nil

20.Β Description ofΒ sharesΒ or debentures involved (classΒ and number)

Ordinary shares of 1 pence each

a) Alan Brown 2,144,092Β  Performance share plan awards

b) Andy Ransom 1,037,464Β  Performance share plan awards

c) Michael MurrayΒ  922,190Β  Performance share plan awards

d) Petar CvetkovicΒ  657,061 Performance share plan awardsΒ 

e) Andy HobartΒ  772,334 Performance share plan awards

f) Martin SawkinsΒ  507,205 Performance share plan awardsΒ 

g) Bryan Kinsella 523,343 Performance share plan awards

h) Peter Lloyd 564,841 Performance share plan awards

i) Peter Slator 691,643 Performance share plan awards

21.Β Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Nil

22.Β Total number ofΒ sharesΒ or debentures over which options held following notification

a) Alan Brown 2,144,092 Performance share plan awards

11,250,000 LTIP awards

b) Andy Ransom 1,037,464 Performance share plan awards

11,250,000 LTIP awards

c) Michael MurrayΒ  2,122,190 Performance share plan awards

d) Petar CvetkovicΒ  1,777,061 Performance share plan awardsΒ 

e) Andy HobartΒ  2,073,497 Performance share plan awards

f) Martin SawkinsΒ  1,201,941 Performance share plan awardsΒ 

g) Bryan Kinsella 1,147,781 Performance share plan awards

h) Peter Lloyd 1,594,727 Performance share plan awards

166,619Β  Pre 2006 ESOS share options

Β 

i) Peter Slator 691,643 Performance share plan awards

23.Β Any additional information

Not applicable

24.Β Name of contact and telephone number for queries

Paul Griffiths,Β Company SecretaryΒ -Β 01293 858 160

25.Β Name and signature of duly authorised officer ofΒ issuerΒ responsible for making notification

Paul Griffiths, Company Secretary

26.Β Date of notification

12Β JuneΒ 2009

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSBSGDLIUBGGCD
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.